Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NETs”

144 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 144 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04919226
What this trial is testing

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE

Who this might be right for
Neuroendocrine Tumors
ITM Solucin GmbH 259
Not applicableStudy completedNCT03017690
What this trial is testing

Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Ipsen 22
Testing effectiveness (Phase 2)Study completedNCT03365791
What this trial is testing

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Who this might be right for
Small Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more
Novartis Pharmaceuticals 76
Early research (Phase 1)Active Not RecruitingNCT04234568
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors

Who this might be right for
Metastatic Digestive System Neuroendocrine NeoplasmMetastatic Neuroendocrine Tumor
National Cancer Institute (NCI) 31
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Not applicableUnknownNCT03689231
What this trial is testing

Volumetric Imaging Follow up of Patients With Liver Metastases of Small Intestinal Neuroendocrine Tumors (NETs).

Who this might be right for
Neuroendocrine TumorsLiver Metastases
Hospices Civils de Lyon 80
Large-scale testing (Phase 3)Looking for participantsNCT07165886
What this trial is testing

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 243
Not applicableStudy completedNCT03817866
What this trial is testing

Chromogranin A as Blood Marker in Cancer Patients

Who this might be right for
Gastric NeoplasmsPancreatic NeoplasmsSmall Intestinal Neoplasms+1 more
Brahms AG 175
Large-scale testing (Phase 3)Study completedNCT03136328
What this trial is testing

Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT Scan

Who this might be right for
Neuroendocrine Tumors
Montefiore Medical Center 11
Early research (Phase 1)Study completedNCT03879694
What this trial is testing

Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Who this might be right for
Lung Atypical Carcinoid TumorLung Typical Carcinoid TumorMetastatic Pancreatic Neuroendocrine Tumor
Roswell Park Cancer Institute 19
Not applicableStudy completedNCT01663831
What this trial is testing

Repellents as Added Control Measure to Long Lasting Insecticidal Nets

Who this might be right for
Malaria
Institute of Tropical Medicine, Belgium 40,000
Not applicableUnknownNCT01491230
What this trial is testing

Neutrophil Extracellular Traps Formation Post-hematopoietic Stem Cell Transplantation

Who this might be right for
Childhood Cancer
Tel-Aviv Sourasky Medical Center 50
Post-approval studies (Phase 4)Study completedNCT01160809
What this trial is testing

Effect of a Combined Use of Mosquito Repellent and Insecticide Treated Net on Malaria in Ethiopia

Who this might be right for
MalariaMosquito RepellentLong Lasting Insecticidal Nets
Malaria Consortium, Ethiopia 6,082
Not applicableUnknownNCT01533779
What this trial is testing

Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity

Who this might be right for
Pediatric Solid MalignanciesPediatric Hematological Malignancies
Tel-Aviv Sourasky Medical Center 50
Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Testing effectiveness (Phase 2)Study completedNCT04785066
What this trial is testing

Efficacy of Pulmozyme® on Arterial Recanalization in Post-thrombectomy Patients Managed for Ischemic Stroke (NETs-target)

Who this might be right for
Ischemic Stroke
Fondation Ophtalmologique Adolphe de Rothschild 39
Not applicableLooking for participantsNCT00747851
What this trial is testing

NETs: Protection or Harm in Neonatal Inflammation or Infection

Who this might be right for
Necrotizing Enterocolitis (NEC)
University of Utah 388
Not applicableStudy completedNCT05413824
What this trial is testing

Neutrophil Side Fluorescent Light (NEU-SFL) in COVID-19 Patients

Who this might be right for
COVID-19
Centre Hospitalier Universitaire de Nīmes 2,233
Large-scale testing (Phase 3)Study completedNCT04852679
What this trial is testing

Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Ipsen 43
Not applicableStudy completedNCT04230161
What this trial is testing

Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Rwanda

Who this might be right for
Malaria
PATH 3,502
Load More Results